genOway
Alexandre Fraichard worked as the Chief Executive Officer at genOway from 1999 onwards. Prior to that, they completed their PhD at ENS Lyon from September 1994 to August 1997.
Alexandre Fraichard completed a Doctor of Philosophy (PhD) degree in Biotechnology from École normale supérieure de Lyon, from 1989 to 1997. Alexandre then pursued an MBA degree in Business from HEC Paris from 1998 to 1999.
This person is not in any teams
genOway
1 followers
Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research. Based on its core business and leading expertise in custom-designed models, the company invests in cancer research, with a growing catalog of currently over 30 translational models for immuno-oncology and immunotherapy. genOway holds all relevant licenses on patented technologies used for its model creation, including the exclusive license under Merck’s foundational CRISPR/Cas9 patents portfolio, which enables the company to guarantee its clients FTO, freedom to operate. Headquartered in Lyon, France, genOway serves clients in 380 academic institutions and 170 life sciences companies, including 17 of the top 20 pharma.